Advertisement

Topics

Advair Diskus

12:43 EST 20th February 2017 | BioPortfolio

Advair Diskus, a respiratory medicine produced by GSK, netted $3.6bn in sales in 2009, making it the fourth most successfull drug (in terms of annual sales).  

Advair is used in the treatment of cases of Asthma  resistant to other medications, and cases of COPD, chronic bronchitis and emphysema. It is a bronchodilator, but also has anti-inflammatory actions.

Source; BioPortfolio.com and Advair.com

Add the Advair News Channel to your RSS reader;

Follow the Advair Twitter feed;

Drug maker: GlaxoSmithKline

Indication(s): Asthma and chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema

2012 sales: $7.904 billion (£5.046 billion)

Quick Search
Advertisement
 

review and buy Advair Diskus market research data and corporate reports here